Tech Company Financing Transactions

Altus Pharmaceuticals Funding Round

Altus Pharmaceuticals closed a $51 million Series C investment round on 5/25/2004. Backers included Warburg Pincus, Nomura Phase4 Ventures and Presidio Partners.

Transaction Overview

Company Name
Altus Pharmaceuticals
Announced On
5/25/2004
Transaction Type
Venture Equity
Amount
$51,000,000
Round
Series C
Investors

Warburg Pincus (Lead Investor) (Stewart Hen)

Nomura Phase4 Ventures

Presidio Partners

U.S. Venture Partners

Proceeds Purpose
Altus expects to use the proceeds from the financing to advance its lead product for pancreatic insufficiency through Phase II clinical trials and to advance and expand its robust pipeline of products to treat patients with chronic gastrointestinal and metabolic diseases.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
333 Wyman St.
Waltham, MA 02451
USA
Phone
(781) 373-6000
Website
www.altus.com
Email Address
[email protected]
Overview
Altus Pharmaceuticals is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases.
Profile
Altus Pharmaceuticals LinkedIn Company Profile
Social Media
Altus Pharmaceuticals Company Twitter Account
Company News
Altus Pharmaceuticals News
Facebook
Altus Pharmaceuticals on Facebook
YouTube
Altus Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Georges Gemayel
  Georges Gemayel LinkedIn Profile  Georges Gemayel Twitter Account  Georges Gemayel News  Georges Gemayel on Facebook
Chief Financial Officer
Jonathan Lieber
  Jonathan Lieber LinkedIn Profile  Jonathan Lieber Twitter Account  Jonathan Lieber News  Jonathan Lieber on Facebook
Chief Medical Officer
Burkhard Blank
  Burkhard Blank LinkedIn Profile  Burkhard Blank Twitter Account  Burkhard Blank News  Burkhard Blank on Facebook
Vice President
Phil Gotwals
  Phil Gotwals LinkedIn Profile  Phil Gotwals Twitter Account  Phil Gotwals News  Phil Gotwals on Facebook
VP - Bus. Development
John Sorvillo
  John Sorvillo LinkedIn Profile  John Sorvillo Twitter Account  John Sorvillo News  John Sorvillo on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/24/2004: Tacit Networks venture capital transaction
Next: 5/25/2004: e-Security venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.